ILEN DIAZ: Open Payments
NPI 1669953535 · MIRAMAR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,404 in 159 payments from 11 companies in 2025. Trend: 2023 $2,233 · 2024 $3,541 · 2025 $4,404
Food & beverage: $3,435Consulting: $900Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 95 | $3,096 |
| ABBVIE INC. | 32 | $596 |
| PFIZER INC. | 11 | $178 |
| Novartis Pharmaceuticals Corporation | 7 | $167 |
| Lilly USA, LLC | 4 | $104 |
| GENZYME CORPORATION | 2 | $86 |
| Incyte Corporation | 3 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $56 |
| Amgen Inc. | 1 | $25 |
| UCB, Inc. | 1 | $24 |
Products named: TREMFYA, SKYRIZI, CIBINQO, RINVOQ, Rhapsido, DUPIXENT, EBGLYSS, OPZELURA.
Industry payments across FL — which companies pay providers there.
